In recent years, increasing evidence (see Weissmann, 1967) has been presented by several workers that release of lysosomal hydrolases during cell injury or excessive phagocytosis might be the final common pathway for the mediation of local injury to the joint in various rheumatic diseases.
In the present investigation we have studied changes in the synovial fluid obtained from inflammatory and non-inflammatory joints, not only of lysosomal enzymes, but of five intracellular enzymes selected to represent different intracellular compartments. Although the study has not revealed a characteristic composition of the synovial fluid for any of the diseases studied, it has indicated that, in the rheumatic diseases, the release of lysosomal enzymes is accompanied by the release of other intracellular enzymes. This suggests that the presence of lysosomal enzymes in the synovial fluid is the result of an overall change in cell permeability or of cell death rather than due to any specific change in the lysosomes.
As kinins have been suggested as mediators of some of the pharmacological effects of the acute inflammatory reponse (Lewis, 1964) , changes in the kinin-forming and kininase activities and alterations in the kininogen content have been studied in the same samples of synovial fluid. Recently, three independent groups of workers have located a weak kinin-forming activity and a kininase activity in leucocytes (Eisen, 1966; Greenbaum and Kim, 1967; Melmon and Cline, 1967) and have suggested that these polymorphonuclear leucocyte-born enzymes play a major role in the continuation of chronic inflammation.
In the present study we describe several findings which suggest that, contrary to previous reports, the constituents of the kinin system in synovial fluid Correspondence should be addressed to: Dr. G. P. Lewis, Research Division, CIBA Laboratories Limited, Horsham, Sussex. * Given at a meeting of the Heberden Society at The Kennedy Institute, London, W.6, on February 14, 1969. are mainly derived from plasma and not from the invading leucocytes.
Material and Methods A total of 64 patients with unilateral or bilateral knee joint effusion due to one of the five major diseases characterized by polyarthritis was studied (Table I) . Their salient clinical features are summarized below:
"Classical" Rheumatoid Arthritis.-35 (26 female, 9 male) of the 64 patients had "definite" or "classical" RA as defined by the revised American Rheumatism Association criteria (Ropes, Bennett, Cobb, Jacox, and Jessar, 1959) . At the time of the study, thirteen of these patients were receiving corticosteroid drugs, and the remaining 22 patients received aspirin in various forms for relief of joint symptoms. The estimated mean prednisolone equivalent dose of corticosteroid drugs was 8 mg./day (range 5-15). The amount of aspirin taken ranged from 2-4 to 4 0 g./day; the estimated average dose being about 3 2 g./day.
Probable and Possible RA.-Seven patients (6 male, one female) had chronic polyarthritis with knee joint effusion but failed to meet all the criteria of Ropes and others (1959) . None gave a positive test for rheumatoid factor in the serum or synovial fluid as judged by the haemagglutination test (Heller, Jacobson, and Kolodny, 1949) , or by the Hyland latex (FII) slide test. Furthermore, a detailed radiological examination of all joints failed to reveal the presence of articular erosions in many of them. They are therefore referred to as having "probable" or "possible" RA. There were no corticosteroid-treated patients in this group.
Osteoarthrosis.-A further group of ten patients (two male, 8 female), had osteoarthrosis of knee joints with normal erythrocyte sedimentation rate (ESR), negative tests for rheumatoid factor in serum and synovial fluid, and radiological changes principally characterized by osteophyte formation and lipping of marginal bone. The majority of those in this group took little in way of analgesics.
Reiter's Disease.-Eight patients (all male) had polyarthritis of acute onset following upon or in association with mucocutaneous ulceration, conjunctivitis, and non-gonoccocal urethro-prostatitis. The minimum duration of polyarthritis in the group was 4 weeks (range 4 to 12). All had spontaneous remission of the arthritis, except one patient in whom the knee joint involvement persisted for a period of 10 years, and who experienced Heparinized synovial fluid and plasma samples were stored at -200 C. until the biochemical and pharmacological examination.
Fresh synovial fluid was diluted with normal saline to obtain the leucocyte counts, and smears were stained to observe cell morphology.
For studies on the distribution of proteins and enzymes between cells and supernatant, fresh synovial fluid was centrifuged at approximately 4,500 r.p.m. for 10 minutes. The supernate was measured, and after several washes, the cell pellet was resuspended in an equivalent amount of saline. Both were then stored at -20°C. until analysis.
BIOCHEMICAL DETERMINATIONS
Protein was determined by the method of Lowry, Rosebrough, Farr, and Randall (1951) ; acid phosphatase (acid phos.) activity was assayed using the method of Harrison (1957) ; /-glucuronidase (,P-gluc.) by the method of Fishman (1963) ; the standard biochemical test combinations (Blehringer and Sohne, GMBH) were employed to determine lactic dehydrogenase (LDH) activity; glutamic-oxalacetic transaminase (GOT) was assayed using BDH enzyme set 2 (based on the method of Karmen, Wr6blewski, and LaDue, 1955) ; glutamic-pyruvic transaminase (GPT) with BDH enzyme assay set 3 (which employs the method of Wr6blewski and LaDue, 1956 ). Potassium was determined using an E.I.L. flame photometer.
PHARMACOLOGICAL TECHNIQUES
Smooth Muscle Stimulating Substances.-The action of the samples was studied on the isolated guinea-pig ileum suspended in Tyrode's solution at 370 C. and the isolated rat uterus suspended in Munsick's solution at 280 C. Contact between synovial fluid and glass was carefully avoided at all times. The samples were incubated and transferred to the organ bath in polythene tubing.
The Kinin System
Kinin-forming activity, kininase activity, and kininogen content were determined on the basis of the following relationships:
Preactive Fig. 1 shows some examples. Dilution 1: 4 in phosphate buffer produced a small formation; addition of purified kininogen to the diluted synovial fluid produced only a small formation; addition of kininase inhibitor and kininogen increased formation but the formed kinins were inactivated after 40 min. incubation. Acidification (Frey, Kraut, and Werle, 1950; Elliott and Lewis, 1965) produced a good formation and the formed kinins remained because acidification destroyed most of the kininase activity; addition of kininogen increased formation even more. Acid activation of kinin-forming enzymes was therefore adopted with addition of kininase inhibitor 0-phenanthroline (Amundsen and Nustad, 1964) to ensure inhibition of any kininase remaining after acidification.
Excess substrate in the form of purified human kininogen was added to each assay to obtain maximum kinin-forming activity.
Procedure: Synovial fluid or plasma 0 3 or 0 5 ml. was acidified to pH 2 by addition of N HCI, and after 10 or 20 min. at 370 C. was neutralized with N NaOH. Some samples were acidified immediately after collection and remained at pH 2 until tested. The mixture was incubated in 0 1iM phosphate buffer at pH 7*4 with purified kininogen (0 * 5-1 *0 mg.) in the presence of kininase inhibitor phenanthroline (10-4M). The total volume of the mixture was 2 ml. and at various time intervals aliquots of between 0 05 and 0 2 ml. were taken and assayed on the isolated rat uterus against a standard of synthetic bradykinin.
In some experiments the kinin-forming enzymes were activated by dilution with Tyrode solution or by glass contact. In the contact activation experiments the sample was incubated with glass ballotini (1 g./ml.), 0-phenanthroline 10-4 g./ml., and kininogen. Maximum formation occurred after 10 to 20 min. Kininase Activity.-After addition of soya bean trypsin inhibitor to prevent any formation of kinin, the sample was incubated with bradykinin and the rate of inactivation followed. Sufficient bradykinin was added to make the amount of kinin already present negligible.
Procedure: Synovial fluid or plasma 0 3 or 0 5 ml. was incubated in phosphate buffer at pH 7-4 with synthetic bradykinin (500 ng./ml. final concentration) in the presence of soya bean trypsin inhibitor 10-4 g./ml. The total volume of the mixture was 2 ml. and an aliquot of 0-05 ml. was taken every 5 min. and assayed on the isolated rat uterus against a standard of synthetic bradykinin.
Kinins.-Kinins were assayed by direct application of fluids to the isolated rat uterus in the presence of atropine D 10-7 g./ml., mepyramine 10-7 g./ml., or BOL 10-6 g./ml., or 10-7 g./ml. In addition, some samples were incubated with chymotrypsin to confirm the peptide nature of the substance.
To prevent destruction of kinin which might be present, some samples were added to boiling ethanol immediately after collection and boiled for 10 minutes. After evaporation of the ethanol, the dried residue was dissolved in a volume of saline equal to that of the original sample before assay.
Preparation of Purified Kininogen.-Kininogen was purified from freshly collected human plasma according to the method of Brocklehurst and Mawer (1966) . Before use, this powder was dissolved in distilled water to a concentration of 1 mg. protein/ml. Incubation of 0 5 ml. of this kininogen for 30 min. with trypsin 200 ,ug./ml. in 0 IM phosphate buffer pH 7*4 (total volume 2 ml.) produced 300-400 ng. bradykinin/mg. of protein.
Incubation of the kininogen in phosphate buffer without the trypsin failed to forn kinin. Incubation of the kininogen with synthetic bradykinin in phosphate buffer caused no destruction of the bradykinin. In some preparations, frce kinins were detected but in such small amounts (less than 1 ng./ml.) that they did not interfere with the assays.
Results
Pharmacological Activity SMOOTH MUSCLE STIMULANTS.-Alcoholic extracts of synovial fluid and plasma caused contraction of the rat uterus. Part of this activity was probably due to the presence of a kinin as its action was not reduced by antagonists of histamine, (mepyramine 10-7 g./ml.) acetylcholine (atropine 10-7 g./ml.) and only slightly reduced by the antagonist of 5-hydroxytryptamine, bromolysergic acid diethylamide (BOL 10-7 g./ml. Values given in ng. bradykinin formed per ml. synovial fluid or plasma ± standard error. Number of samples tested given in brackets. Maximum formation is that which occurred within 60 min.
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All incubations were carried out at 380 C.
After acid treatment, kinin formation continued after 10 min. considerably more so than when activation ( pH Requirements.-It has recently been reported (Greenbaum and Kim, 1967 ) that rabbit polymorphonuclear leucocytes contain an enzyme which is capable of forming kinins at pH 5 when incubated with human kininogen. In the present experiments, rheumatoid synovial fluid, which contains many polymorphonuclear leucocytes (vide infra), was acidified (as described under Methods) and instead of neutralizing to pH 7 4 the pH was brought to 5*0. Incubation now failed to produce kinin formation, as shown in Fig. 2 . However, when this acid incubation mixture was subsequently neutralized and incubated at pH 7 4, kinin formation commenced.
Inhibitors.-Kinin formation in synovial fluid like that in plasma was inhibited by soya bean trypsin inhibitor 100 pg./ml. Trasylol 350-750 u./ml., a protease inhibitor extracted from bovine lung, also caused some inhibition of kinin formation in synovial fluid and plasma. Again, this is not in agreement with the findings of Greenbaum and Kim (1967) for the leucocyte kinin-forming enzyme. KININASE ACIIvITY.-When bradykinin is incubated with synovial fluid or plasma under the conditions described in the methods, the peptide is destroyed within a few minutes. In order to obtain some quantitative measure of the amount of enzyme activity present, the body fluids were diluted with buffer at pH 7*4. Under these conditions it was found that the half-life of bradykinin was about the same in synovial fluid as in plasma.
As with kinin-forming activity, the kininase enzyme resembles plasma kininase and is different to that found by Zachariae, Malmquist, and Oates (1966) and Greenbaum and Kim (1967) to be present in polymorphonuclear leucocytes. As shown in Fig.  3 (opposite), the kininase activity in synovial fluid and in plasma is inhibited by EDTA. However, DFP, which inhibits the bradykinin-destroying activity of leucocytes, does not reduce the kininase activity of synovial fluid or plasma. Responses of the isolated rat uterus to bradykinin (doses in ng./bath) and to aliquots of mixtures containing acid activated non-centrifuged synovial fluid 0 3 ml., kininogen 0 6 mg., 0-phenanthroline 10' M, and either phosphate buffer at pH 7-4 or acetate buffer at pH 5-0 up to I -2 ml. Samples were neutralized before adding to the organ bath. Volumes of aliquots added to the organ bath are given in ml. At the arrow, the mixture at pH 5 0 was neutralized to pH 7-4 with N NaOH and phosphate buffer. Responses of the rat uterus to bradykinin (doses given in ng./bath) and to 0 05 ml. of mixtures containing non-centrifuged synovial fluid 0 3 ml. or plasma 0 *2 ml., bradykinin I pg., soya bean trypsin inhibitor 10-4 g./ml., EDTA 10-4M, and phosphate buffer pH 7-4 up to 2 ml. Control mixtures in which EDTA was omitted were incubated simultaneously. All incubations were made at 38°C. The times at which aliquots were taken and added to the organ bath are given.
When tested at pH 5, only a small amount of bradykinin-destroying activity remained. It was not significantly different whether the cells were present or not. KININOGEN CONTENT.-The concentration of kininogen was found to be lower in synovial fluid than in plasma as also was the concentration of protein (Figs 4 and 5) . But, although it bore some relationship to the protein concentration when calculated in terms of activity per mg. protein, the kininogen in synovial fluid was lower than in plasma.
ORIGIN OF KININ ENZYMES. -Fig. 4 shows the kinin-forming activity, the kininase activity, and the kininogen content of samples of plasma and cellcontaining and cell-free synovial fluid. These results show no difference between the activities in the cell-free and cell-containing synovial fluid, although the activities in plasma were significantly higher.
These findings strongly suggest that the components of the kinin-system (precursors of kininforming enzymes, kininogen and kininase) in the synovial fluid are mainly derived from plasma and not from the leucocytes and other cells present in the synovial fluid. The inference was furthermore supported by results of analysis of the cell pellet and synovium. Pellet.-Centrifugation of the synovial fluid results in the cell-free synovial fluid and a pellet consisting of leucocytes, synovial cells, and debris. In several experiments this pellet was re-suspended in the original volume of saline. The results given in Table III show that, while the kinin-forming activity of the re-suspended cells was only 10 to 60 ng./ml., the activity of the cell-free supernatant was 300-2,000 ng./ml. In contrast, the concentration of the intracellular enzymes acid phos., P-gluc., and GOT was greater in the small volume occupied by the cells than in the whole supernatant.
One possibility was that the cells contained not a kinin-forming enzyme but an activator of such an enzyme. This possibility was tested by incubation of the cells with synovial fluid or with plasma in the presence of excess substrate, but no additional formation could be obtained. In four experiments in which kinin formation in plasma was examined alone and in the presence of cell suspension, the values were 20, 240, 800, 80 ng./ml. alone, and 60, 80, 1,440, 40 ng./ml. in the presence of cells respectively.
Another possibility to be considered was that the cells contained a kinin-forming enzyme with an acid pH optimum. However, when the incubations were carried out at pH 5, the small amount of kinins formed (3 to 10 ng./ml.) was no greater than at pH 7*4.
The kininase activity of the cell suspension was small. When incubated with bradykinin at pH 7X4 kininase activity could only be detected after several hours. No activity could be detected at pH 5 0 even after 20 hours' incubation.
Synovium.-In two patients the enzyme levels in the synovium were examined after synovectomy. The tissue was immediately frozen until it could be homogenized. This was carried out in an Ultra Turrax after adding 2 vol. Tyrode solution per g. tissue. The homogenate was frozen and thawed twice before centrifugation at 14,000 G. The supematant was used for assays of intracellular enzymes and kinin enzymes. Table IV shows the high concentrations of intracellular enzymes and potassium in the extract of synovium. The kinin-forming activity was low (5 to 20 ng./ml.) when tested at pH 7 4 or pH 5 0. However, the extracts possessed a high kininase activity, four and thirteen times that of the synovial fluid itself, and this activity was different from that of the plasma kininase since it was not completely inhibited by acid treatment (pH 2 for 10 min.), EDTA 10-3M), cobalt chloride CoCl2
(3 x 10-2M), or iodo-acetic acid (10-3M).
RELATIONSHIP TO DISEASE.-The kinin-forming and kininase activities and kininogen content of samples of synovial fluid collected from patients with RA and Reiter's disease, as seen from the observed range Fig. 5 (see p. 502). In contrast to the findings in case of kinin-forming and kininase activities, the mean acid phos. ,-gluc., LDH, and GOT activities were not only found to be the highest in synovial fluid containing cells, but they were also higher in cell-free synovial fluid than in plasma.
The cell-pellets also revealed a significantly higher acid phos., ,B-gluc., and GOT activities than in plasma, the only exception being LDH. However, as shown in Table IV (above), the synovium was found to contain the highest activities for all the intracellular enzymes.
These findings indicate that the intracellular enzymes may originate not only from the cells present in the synovial fluid but also from those in the synovium lining the joint cavity.
Relationship between lysosomal and cytoplasmic enzymes.-In Fig. 6 (opposite) the acid phos. activity in the non-centrifuged synovial fluid is compared with activities of /-gluc., LDH, GOT, and protein concentration in the same samples of synovial fluid. There is a significant correlation between acid phos. and /-gluc., LDH, and GOT activities, but the degree of correlation between acid phos. and /-gluc. activities is no greater than that between acid phos. and LDH or GOT activities. These data lead us to conclude that increases in the activity of intracellular enzymes in joint diseases are not chiefly confined to those of the lysosomal compartment.
Relationship betweeni disease and composition of synovial fluid and plasma.-The protein concentrations and the activities of acid phos., P-gluc., LDH, and GOT in the cell-containing synovial fluid and plasma collected from all patients are given in Table  VI .
In this investigation we were unable to obtain samples of normal synovial fluid with which to compare the fluid collected from the five groups of patients. However, the results (Table VI) revealed that, although the concentration of protein and the group.bmj.com on July 6, 2017 -Published by http://ard.bmj.com/ Downloaded from enzyme activity in the synovial fluid varied with the type of arthritis, the plasma levels remained relatively constant. Therefore the relationship between the plasma and synovial fluid constituents provides a measure of the biochemical changes taking place in the joint space as a result of synovial inflammation.
The acid phos., ,B-gluc., and LDH activities were significantly higher than the plasma levels in all five disease categories (P <0 05 in osteoarthrosis, and P <0.001 for all other diseases). The mean total GOT activity was higher than the plasma values in patients with "classical" RA and with arthritis with psoriasis, but the differences were statistically significant in "classical" RA only (P <0 05). The total GPT activity remained the same or was lower than the plasma values in all the diseases.
The lowest concentration of protein and of all the intracellular enzymes examined were observed in osteoarthrotic synovial fluid, whereas the highest values were found in the painful knees of patients with "classical" RA. The synovial fluid changes in "probable" and "possible" RA were intermediate between those observed in OA and those in "classical" RA.
The composition of seven samples of synovial fluid from four patients with arthritis and psoriasis closely resembled that in patients with "classical" RA. The mean acid phos. activity in synovial fluid was nine times the mean plasma values in both the diseases; P-gluc. was eight times the mean plasma level in psoriatics and four times that in "classical" RA; LDH was twelve and twenty times higher than the plasma levels in "classical" RA and in psoriatics respectively; GOT was twice the plasma values in both diseases. In Reiter's disease the mean acid phos. and LDH levels in synovial fluid were lower than in the other three inflammatory joint disorders: "classical" RA, "probable" and "possible" RA, and arthritis with psoriasis. -In the present study, the enzyme activity measurable in the cell-free centrifuged synovial fluid has been used as an index of free activity whereas that obtained in cell-containing non-centrifuged synovial fluid has been taken to reflect the total activity.
A comparison of the free and total acid phos., ,B-gluc., LDH, and GOT activities, shown in Table   VII (opposite), revealed that in all the five diseases the free activities were considerably lower than the corresponding total activities.
In patients with osteoarthrosis, "probable" and "possible" RA, and Reiter's disease, the free activities of all four enzymes were found to be equal to or lower than the corresponding plasma values given in Table V . These observations suggest that the enzyme activities in the synovial fluid from patients with osteoarthrosis, "probable" and "possible" RA, and Reiter's disease were chiefly confined to the cellular compartment.
The relationship between the free and total activities and plasma in patients with "classical" RA and arthritis with psoriasis was somewhat different, and varied from one intracellular enzyme to another. The free acid phos. and /-gluc. activities in "classical" RA and psoriasis were higher than the plasma values, but the mean differences were statistically significant in both the diseases only in respect of acid phos. (P <0 05). The free LDH, and, to a lesser extent, the GOT activities, were also higher than the plasma levels, but the differences were not statistically significant. Thus, in "classical" RA and arthritis with psoriasis, an appreciable leakage of intracellular enzymes had occurred in respect of acid phos., ,B-gluc., and LDH, and to a lesser extent of GOT.
In Reiter's disease, although the total acid phos.
and /-gluc. activity was less than in RA, the enzyme 
Discussion
The present results indicate that the major constituents of the kinin-system are present in pathological joint fluid. The concentration of kininogen in synovial fluid was considerably lower than in plasma even allowing for the difference in the concentration of protein between the two body fluids. This finding could be a reflection of the utilization of kininogen in the formation of kinins during the chronic inflammation. On the other hand, the kinin-forming activity in synovial fluid following mild activation with dilution or glass contact or after stronger activation by lowering pH, was also found to be lower than the plasma activities. It is possible therefore that these low activities indicate a low kinin-forming potential in the joint which could not be consistent with the view that kinins play a major role in joint inflammation.
The relevance of the free kinin activity found in synovial fluid is doubtful. The extent of free kinin activity in a body fluid is not only due to the kinin-forming activity but also depends on the kininase activity in the same fluid. The present results show that kininase activity is as high in synovial fluid as in plasma. The synovium itself might well be the richest, and an as yet unidentified, source of kininase in the joint.
In view of the high kininase activity in the synovial fluid and the synovium, it seems unlikely that free kinins will be found in the fluid even from acutely inflamed joints, as the peptides would be inactivated almost as quickly as they were formed and had exerted their pharmacological action. It is, therefore, difficult to assess the significance of the finding of Melmon, Webster, Goldfinger, and Seegmiller (1967) that the amount of free kinins present in rheumatoid synovial fluid "seemed to correlate well with the severity of symptoms in selected individual patients".
Removal of cells present in the synovial fluid by centrifugation did not alter the kinin-forming or kininase activities, both of which remained the same in cell-free and cell-containing synovial fluid. These data strongly suggest, that contrary to previous reports (Eisen, 1966; Greenbaum and Kim, 1967; Melmon and Cline, 1967; and Zachariae and others, 1966) , the kinin enzymes in inflammatory joint fluid are not derived from cells present in the synovial fluid.
The suggestion is strengthened even more by the observations that, in comparison with the findings in cell-free synovial fluid, only small amounts of kinin-forming and kininase activities were detectable in the cell-pellet which contained many polymorphonuclear leucocytes, cell debris, and synovial cells. In contrast, removal of cells from the synovial fluid lowered significantly the acid phos., fl-gluc., LDH, and GOT activities. Moreover, the activities of three out of the four enzymes in the pellet were found to be in excess of those observed in the cell-free synovial fluid. The exception was the activity of LDH which was found to be particularly low in all the samples of cell pellet examined, a problem which requires further biochemical investigation. Greenbaum and Kim (1967) have described a kinin-forming enzyme in leucocytes which has an acid pH optimum and is not inhibited by soya bean trypsin inhibitor. However, the present investigation has shown that on neither of these criteria could the kinin-forming activity of synovial fluid be attributed to this enzyme. On the contrary, the nature of the kinin-forming enzyme in the synovial fluid resembles that found in plasma-it acts better at pH 7T4 than at pH 5 0, and it is inhibited by soya bean trypsin inhibitor. The possibility that the cells of the synovial fluid contained an activator of the kinin-forming enzymes was also excluded.
The polymorphonuclear leucocytes have also been reported to contain kininase activity (Eisen, 1966; Zachariae and others, 1966; Greenbaum and Kim, 1967; Melmon and Cline, 1967) . As this leucocyte kininase is not inhibited by EDTA but is inhibited by DFP, while that in synovial fluid is inhibited by EDTA but not by DFP, there seems little doubt that the kininase activity of synovial fluid is not due to this intracellular kininase.
Furthermore, as the kininase in synovial fluid has a very low activity at pH 5 0, it is distinguishable from the catheptic kininase described by Greenbaum and Yamafuji (1966) which has a pH optimum of about pH 5*0. It is possible that the kininase activity found in the synovium itself, which was different from that in the synovial fluid or plasma, can be attributed to one of these intracellular enzymes but enough experimental data have not yet been collected to assess this point. As this kininase activity does not appear to be associated with the cells in the synovial fluid, either in the non-centrifuged suspension or in the pellet after centrifugation, it seems likely that the kininase of the synovium does not originate in the same cells as do acid phos., /3-gluc., LDH, or GOT, and that it might even form part of the structural elements of the synovium.
The highest increases in the intracellular enzyme activities were present in patients with "classical" RA and arthritis with psoriasis. In addition, an appreciable leakage of the enzymes (as reflected by the presence in the cell-free synovial fluid of activities higher than those in the plasma) was observed in these two groups of patients only. Thus, the hypothesis of Weissmann (1967) that the release of lysosomal enzymes may be the final common pathway for mediation of joint injury in the rheumatic diseases is not supported by these findings, as leakage of lysosomal enzymes were observed in only two of the five disease categories studied. Furthermore, cytoplasmic as well as lysosomal enzymes leaked out of the cells, which indicates loss of the permeability of the whole cell rather than of the lysosomes only.
The finding that the highest intracellular enzyme activities were seen in joints of patients with "classical" RA and the lowest in those with osteoarthrosis agrees with many other studies (Jacox and Feldmahn, 1955; Vesell, Osterland, Beam, and Kunkel, 1962; Quatrini and Pignataro, 1962; West, Poske, Black, Pilz, and Zimmerman, 1963; Lehman, Kream, and Brogna, 1964; Caygill and Pitkeathly, 1966) .
In the present study it has also been shown that high enzyme levels are present in the joints of patients with psoriasis. Most surprising of all was the finding that, in patients with Reiter's disease, activities of intracellular enzymes were generally low. The protein concentration and leucocyte counts in patients with this disease were comparable with those of patients with RA-this was consistent with the inflamed condition of the joints in Reiter's disease. But, when we consider the distribution of the intracellular enzymes between cells and supernatant in the joints, it is clear that the difference between RA and Reiter's disease lies in the supernatant and not in the cells. This might well reflect the clinical difference between RA and Reiter's disease; i.e. in RA there is a more marked and sustained hypertrophy of the synovium. Such a view would imply that the increased levels of enzymes in the supernatants from RA joints originates mainly in the synovial lining cells. There was a considerable overlap between the individual enzyme activities in the different diseases, which indicates that measurement of the enzyme activities in synovial fluid has little practical usefulness in the definitive diagnosis of arthritis; an important conclusion also made by Ziff, Simson, Scull, Smith, Shatton, and Mainland (1955) who examined the activity of aminotripeptidase, glycylglycylglycinase in six different joint diseases.
Summary
(1) The activity of intracellular enzymes and of the enzymes of the kinin system has been examined in synovial fluid collected from patients with rheumatoid arthritis and related diseases.
(2) Although the mean activities of the intracellular enzymes varied with the disease, those of the kinin enzymes did not. However, the measurement of enzyme activities in the sypovial fluid would not constitute a reliable diagnostic aid because of the considerable overlap of individual values in patients with different diseases.
(3) The cell-containing, but not the cell-free, synovial fluid in all the joint diseases including osteoarthrosis was found to have acid phosphatase, ,B-glucuronidase, and lactic dehydrogenase activity significantly higher than the corresponding plasma activities. On the other hand, enzymes of the kinin system were present in centrifuged and non-centrifuged synovial fluid in about the same concentration, which was lower than the plasma levels.
(4) In the joints of patients with "classical" rheumatoid arthritis and psoriasis, the activity of intracellular enzymes was higher in cell-free synovial fluid than in plasma. However, not only were the activities of lysosomal enzymes increased, but those of other intracellular enzymes as well. This indicates an alteration in the permeability of the whole cell or cell death rather than any specific alteration of the lysosomal membrane.
(5) Although the pellet obtained after centrifugation of synovial fluid contained high concentrations of intracellular enzymes, it contained only small amounts of kinin enzymes. In addition, the pH optimum and sensitivity to inhibitors of the kinin-forming and kininase enzymes in synovial fluid resemble those of kinin enzymes in plasma and not those reported for kinin enzymes present in polymorphonuclear leucocytes.
(6) It is concluded that the kinin-forming and kininase enzymes in synovial fluid are derived mainly from plasma and not from invading leucocytes.
The DR. JASANI: We did not attempt a formal study, but cells in the fluid, would it be possible to try to relate the we compared the total activities between an aspirin-enzyme activity to some parameter of the permeability treated and a corticosteroid-treated group. There was of the joint? One method might be to try to relate no statistical difference between the two groups in the enzyme activity to the protein content in the joint fluid. case of any of the enzymes studied, but it was noted that the activity tended to be a little higher in the cortico-DR. JASANI: We did in fact measure two parameters, steroid-treated group, irrespective of the type of enzymes vascular permeability by means of total protein content studied.
and cell permeability as measured by the potassium content of the fluid and plasma. (1) Se ha examinado la actividad de enzimas intracelulares y de enzimas del sistema kinin en liquido sinovial obtenido de pacientes con poliartritis reumatoide y enfermedades asociades.
(2) Si bien las actividades medias de las enzimas intracelulares variaban con la enfermedad, aquellas de las enzimas kinin no variaban. Sin embargo, la medida de las actividades enzimaticas en el liquido sinovial no constituira una base segura para el diagn6stico, a causa de la considerable superposicion de valores individuales en pacientes con diferentes enfermedades.
(3) Se descubrio que el fluido sinovial que contentia celulas, pero no aquel libre de celulas, de todas las enfermedades articulares, entre ellas la osteoartrosis, tenia una actividad fosfatasa acida, glucuronidasa ,8 y dehidrogenasa lictea significativamente mayor que las correspondientes actividades del plasma. Por otro lado, enzimas del sistema kinin estaban presentes en el liquido sinovial centrifugado y no centrifugado en aproximadamente la misma concentraci6n, que era menor que los niveles del plasma.
(4) En las articulaciones de pacientes con poliartritis reumatoide "clasica" y con psoriasis, la actividad de las enzimas intracelulares era mayor en el fluido sinovial sin celulas que en el plasma. Sin embargo, no solo aumentaron las actividades de las enzimas lisosomales, sino tambien las de otras enzimas intracelulares. Esto indica una alteraci6n en la permeabilidad de toda la celula o muerte de la celula, mas que alteraci6n especifica alguna de la membrana lisosomal. (5) Si bien el grAnulo obtenido despues de la centrifugacion del liquido sinovial contenia altas concentraciones de enzimas intracelulares, acusaba tan solo pequenas cantidades de enzimas kinin. Ademas, el pH 6ptimo y la sensibilidad a los inhibidores de las enzimas que forman kinin y kininasa en el fluido sinovial se parecen a los de las enzimas kinin en el plasma y no a los que se relacionan con enzimas kinin presentes en leucocitos polimorfonucleares.
(6) Se llega a la conclusion de que las enzimas que forman kinin y kininasa en el fluido sinovial se derivan principalmente del plasma y no de leucocitos invasores.
